|
| |
| | | | 1 | | | DO1.PCCNTR.2073142 ContractData Container |
| | | 1.1 | | | | | | | | | | 1,536,200.00 | 0.00 | 167,706.00 | 0.00 | 1,626,700.00 | 1,703,906.00 |
|
| | | | | | | 1 | | 42272301 - Resucitadores (...)42272301 - Resucitadores manuales |
| 2.3.9.3.01 | Resucitador manual ambu para adulto (L) | 100 | UD | 2,800 | 2,800 | 280,000.00 | | 0.00 | | 18 | 50,400.00 | | 0.00 | 280,000.00 | 330,400.00 | |
|
| | | | | | | 2 | | 42295401 - Lápices de cau(...)42295401 - Lápices de cauterización operados mediante pilas de uso quirúrgico |
| 2.3.9.3.01 | Lapiz de electrocautrio | 500 | UD | 260 | 160 | 80,000.00 | | 0.00 | | 18 | 14,400.00 | | 0.00 | 130,000.00 | 94,400.00 | |
|
| | | | | | | 3 | | 2.3.4.1.01 | Gentamicina | 100 | UD | 100 | 100 | 10,000.00 | | 0.00 | | | 0.00 | | 0.00 | 10,000.00 | 10,000.00 | |
|
| | | | | | | 4 | | 2.3.3.2.01 | Papel de sonografia 110x20 | 300 | UD | 715 | 580 | 174,000.00 | | 0.00 | | 18 | 31,320.00 | | 0.00 | 214,500.00 | 205,320.00 | |
|
| | | | | | | 5 | | 2.3.4.1.01 | Piperaciclina + tazobatan | 120 | UD | 2,800 | 2,800 | 336,000.00 | | 0.00 | | | 0.00 | | 0.00 | 336,000.00 | 336,000.00 | |
|
| | | | | | | 6 | | 42271708 - Máscaras de ox(...)42271708 - Máscaras de oxígeno o partes para uso médico |
| 2.3.9.3.01 | Mascarillas de CPAP (Venilacion mecanica) | 30 | UD | 6,090 | 6,090 | 182,700.00 | | 0.00 | | 18 | 32,886.00 | | 0.00 | 182,700.00 | 215,586.00 | |
|
| | | | | | | 7 | | 2.3.4.1.01 | Lidocaina 2% S/epinefrina IV | 500 | UD | 190 | 190 | 95,000.00 | | 0.00 | | | 0.00 | | 0.00 | 95,000.00 | 95,000.00 | |
|
| | | | | | | 8 | | 42142702 - Catéteres urin(...)42142702 - Catéteres urinarios uretrales |
| 2.3.9.3.01 | Cateter triple | 50 | UD | 4,300 | 4,300 | 215,000.00 | | 0.00 | | 18 | 38,700.00 | | 0.00 | 215,000.00 | 253,700.00 | |
|
| | | | | | | 9 | | 51131607 - Enoxaparina só(...)51131607 - Enoxaparina sódica |
| 2.3.4.1.01 | Enoxaparina 60MG inyectable | 150 | UD | 1,090 | 1,090 | 163,500.00 | | 0.00 | | | 0.00 | | 0.00 | 163,500.00 | 163,500.00 | |
|
|
| | | |
| | | |
|